
Prince Akwasi Mensah
Examiner (ID: 16550, Phone: (571)270-7183 , Office: P/2474 )
| Most Active Art Unit | 2474 |
| Art Unit(s) | 2416, 2474 |
| Total Applications | 590 |
| Issued Applications | 431 |
| Pending Applications | 63 |
| Abandoned Applications | 119 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7468727
[patent_doc_number] => 20040167150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Treatment methods'
[patent_app_type] => new
[patent_app_number] => 10/791477
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3231
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20040167150.pdf
[firstpage_image] =>[orig_patent_app_number] => 10791477
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/791477 | Treatment methods | Mar 1, 2004 | Abandoned |
Array
(
[id] => 6996309
[patent_doc_number] => 20050136087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Stabilized formulation of ivermectin feed premix with an extended shelf life and method of making the same'
[patent_app_type] => utility
[patent_app_number] => 10/790489
[patent_app_country] => US
[patent_app_date] => 2004-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5405
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136087.pdf
[firstpage_image] =>[orig_patent_app_number] => 10790489
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/790489 | Stabilized formulation of ivermectin feed premix with an extended shelf life | Feb 29, 2004 | Issued |
Array
(
[id] => 7276350
[patent_doc_number] => 20040235801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Therapy for stroke'
[patent_app_type] => new
[patent_app_number] => 10/788478
[patent_app_country] => US
[patent_app_date] => 2004-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7272
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235801.pdf
[firstpage_image] =>[orig_patent_app_number] => 10788478
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/788478 | Therapy for stroke | Feb 29, 2004 | Abandoned |
Array
(
[id] => 910491
[patent_doc_number] => 07329682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-12
[patent_title] => 'Method for inhibiting 5-lipoxygenase using a benzoxazole derivative'
[patent_app_type] => utility
[patent_app_number] => 10/789725
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5084
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/329/07329682.pdf
[firstpage_image] =>[orig_patent_app_number] => 10789725
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/789725 | Method for inhibiting 5-lipoxygenase using a benzoxazole derivative | Feb 26, 2004 | Issued |
Array
(
[id] => 7347136
[patent_doc_number] => 20040192694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Use of COX-2 inhibitors as gastroprokinetics'
[patent_app_type] => new
[patent_app_number] => 10/786423
[patent_app_country] => US
[patent_app_date] => 2004-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4090
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192694.pdf
[firstpage_image] =>[orig_patent_app_number] => 10786423
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/786423 | Use of COX-2 inhibitors as gastroprokinetics | Feb 24, 2004 | Abandoned |
Array
(
[id] => 7468708
[patent_doc_number] => 20040167147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Oral use of methylnaltrexone and related compounds to induce laxation in chronic opioid users'
[patent_app_type] => new
[patent_app_number] => 10/785320
[patent_app_country] => US
[patent_app_date] => 2004-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8346
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20040167147.pdf
[firstpage_image] =>[orig_patent_app_number] => 10785320
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/785320 | Oral use of methylnaltrexone and related compounds to induce laxation in chronic opioid users | Feb 23, 2004 | Abandoned |
Array
(
[id] => 793216
[patent_doc_number] => 06982262
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-03
[patent_title] => 'Combination of cyamemazine and an atypical neuroleptic'
[patent_app_type] => utility
[patent_app_number] => 10/783451
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1650
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/982/06982262.pdf
[firstpage_image] =>[orig_patent_app_number] => 10783451
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/783451 | Combination of cyamemazine and an atypical neuroleptic | Feb 19, 2004 | Issued |
Array
(
[id] => 8189312
[patent_doc_number] => 08183232
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Therapeutic agent for hemorrhoidal disease'
[patent_app_type] => utility
[patent_app_number] => 10/545910
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3635
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 279
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/183/08183232.pdf
[firstpage_image] =>[orig_patent_app_number] => 10545910
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/545910 | Therapeutic agent for hemorrhoidal disease | Feb 16, 2004 | Issued |
Array
(
[id] => 5694807
[patent_doc_number] => 20060154954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Combinations and use of selected pharmaceutically active compounds'
[patent_app_type] => utility
[patent_app_number] => 10/545031
[patent_app_country] => US
[patent_app_date] => 2004-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25862
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10545031
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/545031 | Combinations and use of selected pharmaceutically active compounds | Feb 15, 2004 | Abandoned |
Array
(
[id] => 7432990
[patent_doc_number] => 20040162306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Use of methylnal trexone and related compounds to treat constipation in chronic opioid users'
[patent_app_type] => new
[patent_app_number] => 10/778268
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8382
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162306.pdf
[firstpage_image] =>[orig_patent_app_number] => 10778268
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/778268 | Use of methylnal trexone and related compounds to treat constipation in chronic opioid users | Feb 11, 2004 | Abandoned |
Array
(
[id] => 7433003
[patent_doc_number] => 20040162308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Use of methylnaltrexone and related compounds for treatment of constipation caused by endogenous opioids'
[patent_app_type] => new
[patent_app_number] => 10/779129
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3577
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162308.pdf
[firstpage_image] =>[orig_patent_app_number] => 10779129
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/779129 | Use of methylnaltrexone and related compounds for treatment of constipation caused by endogenous opioids | Feb 11, 2004 | Abandoned |
Array
(
[id] => 7432999
[patent_doc_number] => 20040162307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Use of methylnaltrexone and related compounds to induce laxation in chronic opioid users'
[patent_app_type] => new
[patent_app_number] => 10/779128
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8386
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162307.pdf
[firstpage_image] =>[orig_patent_app_number] => 10779128
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/779128 | Use of methylnaltrexone and related compounds to induce laxation in chronic opioid users | Feb 11, 2004 | Abandoned |
Array
(
[id] => 7433578
[patent_doc_number] => 20040162348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders'
[patent_app_type] => new
[patent_app_number] => 10/776226
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10320
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162348.pdf
[firstpage_image] =>[orig_patent_app_number] => 10776226
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/776226 | Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders | Feb 11, 2004 | Abandoned |
Array
(
[id] => 5603027
[patent_doc_number] => 20060293372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Beta-sheet mimetics and methods relating to the use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/774043
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 39044
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20060293372.pdf
[firstpage_image] =>[orig_patent_app_number] => 10774043
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/774043 | Beta-sheet mimetics and methods relating to the use thereof | Feb 4, 2004 | Abandoned |
Array
(
[id] => 7306477
[patent_doc_number] => 20040116505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Treatment of tics, tremors and related disorders'
[patent_app_type] => new
[patent_app_number] => 10/468937
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4201
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116505.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468937
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468937 | Treatment of tics, tremors and related disorders | Feb 4, 2004 | Abandoned |
Array
(
[id] => 7239988
[patent_doc_number] => 20040157924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Novel methods for using alkanoyloxymethyl esters'
[patent_app_type] => new
[patent_app_number] => 10/769908
[patent_app_country] => US
[patent_app_date] => 2004-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4262
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157924.pdf
[firstpage_image] =>[orig_patent_app_number] => 10769908
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/769908 | Novel methods for using alkanoyloxymethyl esters | Feb 2, 2004 | Abandoned |
Array
(
[id] => 7239500
[patent_doc_number] => 20040157887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same'
[patent_app_type] => new
[patent_app_number] => 10/769021
[patent_app_country] => US
[patent_app_date] => 2004-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35419
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157887.pdf
[firstpage_image] =>[orig_patent_app_number] => 10769021
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/769021 | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same | Feb 1, 2004 | Abandoned |
| 90/006921 | METHODS OF TREATING ANDROGEN DEFICIENCY IN MEN USING SELECTIVE ANTIESTROGENS | Jan 25, 2004 | Issued |
Array
(
[id] => 7237971
[patent_doc_number] => 20050080055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Method of treating breast cancer with androgen receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/760152
[patent_app_country] => US
[patent_app_date] => 2004-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14632
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20050080055.pdf
[firstpage_image] =>[orig_patent_app_number] => 10760152
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/760152 | Method of treating breast cancer with androgen receptor antagonists | Jan 19, 2004 | Abandoned |
Array
(
[id] => 7347426
[patent_doc_number] => 20040192739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Methods of treating conditions associated with an Edg-2 receptor'
[patent_app_type] => new
[patent_app_number] => 10/759992
[patent_app_country] => US
[patent_app_date] => 2004-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16165
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192739.pdf
[firstpage_image] =>[orig_patent_app_number] => 10759992
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/759992 | Methods of treating conditions associated with an Edg-2 receptor | Jan 15, 2004 | Abandoned |